المؤلفون: Honcharenko, D, Rocha, CSJ, Lundin, KE, Maity, J, Milton, S, Tedebark, U, Murtola, M, Honcharenko, M, Slaitas, A, Smith, CIE, Zain, R, Stromberg, R

المصدر: Nucleic acid therapeutics. 32(3):221-233

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:149222278

المؤلفون: Rocha, CSJ, Wiklander, OPB, Larsson, L, Moreno, PMD, Parini, P, Lundin, KE, Smith, CIE

المصدر: Journal of molecular and cellular cardiology. 82:186-193

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:131233770

المؤلفون: Moreno, PMD, Geny, S, Pabon, YV, Bergquist, H, Zaghloul, EM, Rocha, CSJ, Oprea, II, Bestas, B, El Andaloussi, S, Jorgensen, PT, Pedersen, EB, Lundin, KE, Zain, R, Wengel, J, Smith, CIE

المصدر: Nucleic acids research. 41(5):3257-3273

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:126661365

المؤلفون: Aoki, Y, Rocha, CSJ, Lehto, T, Miyatake, S, Johansson, H, Hashimoto, Y, Nordin, JZ, Mager, I, Aoki, M, Graham, M, Sathyaprakash, C, Roberts, TC, Wood, MJA, Behlke, MA, El Andaloussi, S

المصدر: Frontiers in physiology. 12:689179

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:147972142

المؤلفون: Saher, O, Rocha, CSJ, Zaghioul, EM, Wiklander, OPB, Zamolo, S, Heitz, M, Ezzat, K, Gupta, D, Reymond, JL, Zain, R, Hollfelder, F, Darbre, T, Lundin, KE, El Andaloussi, S, Smith, CIE

المصدر: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 132:29-40

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:139517009

المؤلفون: Rocha, CSJ, Lundin, KE, Behlke, MA, Zain, R, EL Andaloussi, S, Smith, CIE

المصدر: Nucleic acid therapeutics. 26(6):381-391

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:134599441

المؤلفون: Bergquist, H, Rocha, CSJ, Alvarez-Asencio, R, Nguyen, CH, Rutland, MW, Smith, CIE, Good, L, Nielsen, PE, Zain, R

المصدر: PloS one. 11(11):e0165788

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:134728853

المؤلفون: Milton, S, Honcharenko, D, Rocha, CSJ, Moreno, PMD, Smith, CIE, Stromberg, R

المصدر: Chemical communications (Cambridge, England). 51(19):4044-4047

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:130846840

المؤلفون: Gennemark P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden. peter.gennemark@astrazeneca.com.; Department of Biomedical Engineering, Linköping University, SE-581 83 Linköping, Sweden., Walter K; Inhalation Product Development, Pharmaceutical Technology and Development, Operations, AstraZeneca, SE-431 50 Gothenburg, Sweden., Clemmensen N; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Rekić D; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Nilsson CAM; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Knöchel J; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Hölttä M; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Wernevik L; Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Rosengren B; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Kakol-Palm D; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Wang Y; Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA., Yu RZ; Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA., Geary RS; Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA., Riney SJ; Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA., Monia BP; Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA., Isaksson R; Early Biometrics and Statistical Innovation, Data Science and Artificial Intelligence, BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Jansson-Löfmark R; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Rocha CSJ; Functional and Mechanistic Safety, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Lindén D; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Hurt-Camejo E; Translational Science and Experimental Medicine, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Crooke R; Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA., Tillman L; Ionis Pharmaceuticals Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA., Rydén-Bergsten T; Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Carlsson B; Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Andersson U; CVRM Safety, Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Elebring M; Drug Metabolism and Pharmacokinetics, Research and Early Development, Cardiovascular, Renal, and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Tivesten A; CVRM CMC Projects, Pharmaceutical Sciences, R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden., Davies N; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, SE-431 50 Gothenburg, Sweden.

المصدر: Science translational medicine [Sci Transl Med] 2021 May 12; Vol. 13 (593).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

مواضيع طبية MeSH: Oligonucleotides, Antisense* , PCSK9 Inhibitors*, Animals ; Dogs ; Macaca fascicularis ; Rats ; Serine Endopeptidases

المؤلفون: Rocha CSJ; Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. cristina.rocha@astrazeneca.com.

المصدر: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2019; Vol. 2036, pp. 73-90.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029 (Electronic) Linking ISSN: 10643745 NLM ISO Abbreviation: Methods Mol Biol Subsets: MEDLINE

مواضيع طبية MeSH: Gene Expression Regulation* , RNA Splicing*, Oligonucleotides, Antisense/*genetics, Cell Line ; Humans ; Proprotein Convertase 9/genetics ; RNA, Messenger/genetics